A dangerous delta mutation is spreading in Lithuania: even more new cases have been identified



[ad_1]

There were also 536 cases of the Alpha strain registered for the first time in Great Britain, one case of the Gamma strain registered for the first time in Brazil and eight cases of B.1.620 registered in Lithuania in Anykščiai.

The laboratory of the European Center for Disease Prevention and Control (ECDC) analyzed 514 samples, of which 495 cases belonged to the Alpha variant, as well as eight new cases of the B.1.620 virus line, five new cases of the Delta variant and a new one. case of the Gamma variant.

In the laboratory of the Vilnius University Life Sciences Center, 48 samples were examined, of which 41 cases belong to the Alpha variant. Six new cases of the Delta variant were also identified in this laboratory.

So far, a total of 14 thousand. Sequencing of 81 samples and detection of 10 thousand. 24 cases of Alpha variant, 13 Beta variant, 258 B.1.620 variant, 7 Gamma variant, and 23 Delta variant virus lines.

Last day, 4,151 people received the first dose of COVID-19, the second, 20 thousand. 256, released by the Statistics Department on Wednesday.

In the country, COVID-19 has so far received the first dose of 1 million vaccines. 235 thousand 439 people, two – 979 thousand. 640.

At least one dose of the vaccine was 53.9%. more than 80, 68.5 percent. – Population from 75 to 79 years old, 70.7 percent. – 70-74 years and 69.2 percent. – Population from 65 to 69 years old.

In the 55-64 age group, 57.1% are vaccinated, in the 45-54 age group – 50.6%, in the 35-44 age group – 48.8%, in the 25 group -34 years – 41.9 percent, group of 16 to 24 years – 39.7 percent. population. 7.2% of children aged 12-15 years were vaccinated.

These figures increased around 0.1-0.3 percentage points per day.

In Lithuania, 44.2% have received at least one coronavirus vaccine. people: 0.2 percentage points more than a day before.

In total, Lithuania has received 2 million. 926,855 doses of vaccine, of which 2 million. 473 thousand 575 are delivered to vaccination centers. Here 2 million were used. 215 thousand 79 doses of vaccine.

The number of unused vaccine doses continues to grow and currently exceeds 711.7 thousand. The day before there were 545.6 thousand of them.

Last day 40 new cases of COVID-19 were detected, no deaths were recorded, the Department of Statistics announced on Wednesday.

Lithuania has entered the green zone according to morbidity indicators: the number of new cases is 100 thousand. the 14-day population is currently 24.8 and the proportion of positive tests is half a percent.

5,875 molecular tests (PCR) and 3,905 antigens were carried out in the country on suspicion of coronavirus.

In Lithuania, since the start of the pandemic, COVID-19 has affected 278 thousand people. 769 people.

Statistically recovered and there are currently 267 thousand alive. 565 people, statistically 770 people are currently ill.

A total of 4,383 people died in Lithuania from COVID-19. 8,912 deaths have been linked to this infectious disease, both directly and indirectly.

NVSC: COVID-19 outbreaks have nearly halved in a week

COVID-19 outbreaks in the country have halved in a week and epidemiologists continue to record a decline in coronavirus outbreaks.

According to the National Center for Public Health (NVSC) on Tuesday, a comparison of the trends recorded on the COVID-19 outbreak map in late May and June shows that active outbreaks fell nearly 90% in one month, from 386 in May. to 46 in June.

According to NVSC doctor epidemiologist Daiva Razmuvienė, epidemiologists continued to record a downward break in the curve of the coronavirus outbreak last week, and these trends are driven by population vaccination.

“What we see in the outbreak curve is gratifying. Last week, the downtrend in breakouts not only persisted, but also saw a more significant break in the curve than in the weeks before it reached around 30 percent each week. This means that the impact of vaccination on the epidemiological situation is particularly significant. This is a very good and long-awaited result, which shows that we can defeat the virus through vaccination, ”said D. Razmuvienė.

He urged residents to continue to actively vaccinate and “build a success story together and meet it in the fall, not the virus.”

According to NVSC data, last week in Lithuania 60 percent. there was a decrease in active outbreaks registered in educational institutions. His specialists registered 12, up from 30 the week before. Half of the outbreaks were in the food industry, furniture manufacturing, construction and logistics, and transportation sectors.

At the time, trading companies, experts say, looked at 40 percent last week. fewer active shoots compared to week 24 of the year. His epidemiologists registered four, a week before seven.

According to experts, the outbreak curve in the manufacturing sector fell more slowly last week than in the previous week, that is, the number of outbreaks in companies fell by a fifth during the week. There were also no more active outbreaks in sewing companies: in the spring, more than 20 companies were registered in this area.

At the end of last week, a total of 46 active outbreaks of COVID-19 were recorded in Lithuania, compared with 88 the previous week. 138 active outbreaks of COVID-19 were detected from June 7 to 13 and 212 outbreaks from May 31 to June 6. At the end of May there were 331 outbreaks and 448 outbreaks from May 10 to 16.

The NVSC recalls that an outbreak is the sudden spread of a communicable disease that affects a limited number of people or a limited area, that is, two or more interrelated cases of the disease in time and space.

The NVSC recalls that Biontech and Pfizer can be given to people over 12 years of age, and that the remaining vaccines can be given to all adults.

It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source.



[ad_2]